STABLON

This brand name is authorized in Austria, Brazil, France, Hong Kong SAR China, Malta, Singapore, Tunisia, Turkey.

Active ingredients

The drug STABLON contains one active pharmaceutical ingredient (API):

1	Tianeptine UNII YG0E19592I - TIANEPTINE SODIUM
	Tianeptine is an antidepressant. In man, tianeptine is characterised by marked action on somatic complaints, especially gastrointestinal complaints related to anxiety and mood disturbances. Moreover, tianeptine has no effect on sleep and alertness nor on the cholinergic system (no anticholinergic symptoms).
	Read more about Tianeptine

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
STABLON Coated tablet	MPI, EU: SmPC	Medicines Authority (MT)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N06AX14	Tianeptine	N Nervous system → N06 Psychoanaleptics → N06A Antidepressants → N06AX Other antidepressants
Discover more medicines within N06AX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	531301301117319, 531301302113317, 531318010008703, 531318010008803
FR	Base de données publique des médicaments	65411280
HK	Department of Health Drug Office	51215
MT	Medicines Authority	MA066/01201
SG	Health Sciences Authority	11182P
TN	Direction de la Pharmacie et du Médicament	6353072
TR	İlaç ve Tıbbi Cihaz Kurumu	8699552090236